🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sharareh Siamakpour‐Reihani

Duke University

ORCID: 0000-0002-2837-443X
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia”.

Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia

PLoS ONE(2022)10.1371/journal.pone.0268963
N/A
0.208DataRank · unranked
3 citations

Felicia Cao, Jing Lyu, Yi Ren, Andrew B. Nixon, Jichun Xie +10 more

H2O2‐Driven Anticancer Activity of Mn Porphyrins and the Underlying Molecular Pathways

Oxidative Medicine and Cellular Longevity(2021)10.1155/2021/6653790
N/A
0DataRank · unranked
58 citations

Artak Tovmasyan, Zhiqing Huang, Weina Duan, Li Du, Sharareh Siamakpour‐Reihani +5 more

A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant

PLoS ONE(2021)10.1371/journal.pone.0252995
N/A
0DataRank · unranked
5 citations

Sharareh Siamakpour‐Reihani, Lauren Bohannan, Yi Ren, Alexander B. Sibley, Jeff Sheng +24 more

The Role of Calcineurin/NFAT in SFRP2 Induced Angiogenesis—A Rationale for Breast Cancer Treatment with the Calcineurin Inhibitor Tacrolimus

UNC Libraries(2021)10.17615/5y2x-wk13
N/A
0DataRank · unranked
0 citations

Xiang Shen, Desh Bandhu Nepal, Sharareh Siamakpour‐Reihani, Andrew Courtwright, Jerry Usary +6 more

Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.018
N/A
0DataRank · unranked
17 citations

Yi Ren, Yen P. Lowder, Sharareh Siamakpour‐Reihani, Sendhilnathan Ramalingam, Kristi Romero +45 more